-
The Applications of 3-(HYDRAZINO)PYRIDAZINE HYDROCHLORIDE
Time of Update: 2023-05-17
Its ability to enhance the effectiveness of other chemicals makes it a valuable ingredient in the production of pharmaceuticals, agrochemicals, synthetic fibers, polymers and dyes and pigments.
-
Lancet Oncol: Treatment of Relapsed/Refractory Malignant Pleural Mesothelioma with EZH2 Inhibitor Tzemetostat
Time of Update: 2022-08-12
9 weeks, the disease control rate in patients with BAP1 inactivation at week 12 was 54%After a median follow-up of 35.
9 weeks, the disease control rate in patients with BAP1 inactivation at week 12 was 54%After a median follow-up of 35.
-
Acetylene-based coal chemical technology is expected to open a new round of coal chemical investment market
Time of Update: 2022-02-19
In addition, Shi Xuejun also revealed that as of now, Shenwu Group is promoting 10 acetylene-based coal chemical projects with a total investment of 90.
-
Ganley announced that TRS-β asC41, has been well-datated in Phase I clinical trials
Time of Update: 2021-01-31
In a multi-dose incremental clinical study, after 14 days of daily oral TREATMENT of ASC41 tablets, the LDL-C and triglyceride (TG) indicators of the subjects showed clinical significance and statistically significant reductions relative to the placebo group, as shown in the table below: In 14 days of treatment, ASC41 did not have class 3 or above adverse events, adverse events or early on-stop events in all dosage groups.
-
Measuring Soil Salinity
Time of Update: 2020-11-07
A range of both field and laboratory procedures exist for measuring soil salinity.
In the field, soil salinity is usually inferred from apparent electrical conductivity (EC a ) using a range of devices, depending on the required depth of analysis, or size of the survey area.
-
20 years of great innovation! Lilly 5-HT1F Agonist Reyvow New Phase III Study: Take the drug for 1 hour and the pain disappears for 48 hours
Time of Update: 2020-09-26
!--,2020 // -- Eli Lilly recently presented the results of a new Phase III clinical study on the evaluation of the oral drug Reyvow (lasmitan) C-V tablet for the treatment of migraine attacks in adult patients at the PAINWeek®2020 Real-Time Virtual Conference.
